Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Researchers engineered a mutant ACE2 decoy that effectively protected human lung epithelia from SARS-CoV-2 infection by competitively binding to its spike protein.

Related Keywords

Aimee Molineux ,Neha Mathurmar ,Neha Mathur ,Kateryna Kon Shutterstock ,Trends In Pharmacological Sciences ,Pharmacological Sciences ,Angiotensin ,Ngiotensin Converting Enzyme 2 ,Coronavirus Disease Covid 19 ,Covid 19 ,Nzyme ,Ce2 ,Antibodies ,Binding Affinity ,Fell ,Coronavirus ,Bedema ,N Vitro ,Lungs ,Micron ,Pandemic ,Protein ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Ransgenic ,Virus ,